Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2022
Filter by date:
Showing 1107 press releases before 2022
-
Bydureon receives positive EU CHMP opinion for EXSCEL cardiovascular outcomes data
-
European Commission approves Imfinzi for locally-advanced, unresectable NSCLC
-
Farxiga achieved a positive result in the Phase III DECLARE-TIMI 58 trial, a large cardiovascular outcomes trial in 17,000 patients with type-2 diabetes
-
AstraZeneca presents further data showing the interconnectivity between cardiovascular and renal risks in diabetes at EASD 2018
-
Fasenra shows consistent safety and sustained efficacy in long-term Phase III BORA trial in severe eosinophilic asthma
-
The Lancet Respiratory Medicine publishes first Phase III trial for PT010 triple combination therapy in moderate to very severe chronic obstructive pulmonary disease
-
US FDA approves Lumoxiti (moxetumomab pasudotox-tdfk) for certain patients with relapsed or refractory hairy cell leukaemia
-
AstraZeneca to present Fasenra long-term safety and efficacy data at European Respiratory Society International Congress 2018
-
Tezepelumab granted Breakthrough Therapy Designation by US FDA
-
Update on TULIP 1 Phase III trial for anifrolumab in systemic lupus erythematosus
Latest articles and press releases
All of our latest press releases and articles are available to explore
